OBJECTIVE: Given the significantly increased number of individuals prescribed stimulants in the past decade, there has been growing concern regarding the risk of cardiovascular events among adults on stimulant therapy. We aimed to quantify the added risk of cardiovascular events by prescription stimulant use and characterize patients who were adversely affected.
